935248-16-1

Basic information

• Product Name: 6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-one
• Synonyms: 6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-one
• CAS NO: 935248-16-1
• Molecular Weight: 340.766
• Mol File: 935248-16-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-one(935248-16-1)
• EPA Substance Registry System: 6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-one(935248-16-1)

Safety Data

• Hazardous Substances Data: 935248-16-1(Hazardous Substances Data)

Upstream product

• 13623-25-1 6-methoxy-2,3-dihydro-1H-inden-1-one 
• 62803-47-8 6-hydroxy-1-indanone 
• 73217-30-8 3-(chloromethyl)-5-(4-chlorophenyl)-1,2,4-oxadiazole 

Downstream Products

• 935248-19-4 di-t-butyl {6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-malonate 
• 935248-18-3 2-[{6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-(2-hydroxy-ethyl)-amino]-ethanol 
• 935248-20-7 {6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-acetic acid 
• 935248-23-0 {6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-propionitrile 
• 935248-21-8 {6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-ethanol 
• 935248-40-1 3-{6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl}-propionaldehyde 
• 935248-22-9 3-[3-(2-chloro-ethyl)-indan-5-yloxymethyl]-5-(4-chloro-phenyl)-[1,2,4]oxadiazole 
• 935248-17-2 6-[5-(4-chloro-phenyl)-[1,2,4]oxadiazol-3-ylmethoxy]-indan-1-yl-chloride 

Relevant articles and documents

A novel, non-substrate-based series of glycine type 1 transporter inhibitors derived from high-throughput screening

The synthesis and structure-activity relationships (SAR) of a series of indane and tetralin inhibitors of the type 1 glycine transporter, derived from a high-throughput screening (HTS) hit, are described. Key modifications that reduced the 5HT1B receptor